Genipin attenuates sepsis by inhibiting Toll-like receptor signaling.

Molecular medicine (Cambridge, Mass.)

Volumn 18, Issue 1, 2012, Pages 455-465

  Kim, Tae Hoon ^a   Yoon, Seong Jin ^b   Lee, Sun Mee ^b  

^a Sungkyunkwan University   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; GENIPIN; HIGH MOBILITY GROUP B1 PROTEIN; IRIDOID; MITOGEN ACTIVATED PROTEIN KINASE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; NITRITE; TICAM 1 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL; ARTICLE; BLOOD; CELL LINE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; LUNG; MALE; METABOLISM; MOUSE; PATHOLOGY; SEPSIS;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; CYTOKINES; HMGB1 PROTEIN; IRIDOIDS; LIVER; LUNG; MALE; MICE; MICE, INBRED ICR; MITOGEN-ACTIVATED PROTEIN KINASES; MYELOID DIFFERENTIATION FACTOR 88; NITRITES; SEPSIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84865622146     PISSN: None     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2011.00308     Document Type: Article

References (0)